Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Main Author: | Karim, Samia Binte |
---|---|
Other Authors: | Azam, Faruque |
Format: | Thesis |
Language: | English |
Published: |
Brac University
2024
|
Subjects: | |
Online Access: | http://hdl.handle.net/10361/23944 |
Similar Items
-
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
by: Hoque, Ismoth Ara
Published: (2024) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
by: Paul, Pulock
Published: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
by: Rahman, Tasnim
Published: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
by: Flora, Sanzida Alam
Published: (2024) -
Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
by: Hasan, Sakib
Published: (2024)